Skip to main content

WEALTH ENHANCEMENT ADVISORY SERVICES, LLC

Position in PACB — Pacific Biosciences Of California, Inc.

CIK 1632972 PLYMOUTH, MN

Position in PACB

as of Jun 30, 2026 · filed Jul 15, 2026
Position Value
$92,368
+$34,736 QoQ
Shares Held
54,981
+25.9% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2
of 6 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 4.2414652334442815.ToString("F0")% Shared 0.ToString("F0")% None 95.75853476655571.ToString("F0")%

Common Shares in PACB Over Time

Shares Held

Position Value (USD)

Derivatives in PACB

reported options exposure · as of Jun 30, 2024
CallValue
$68,500
CallShares
50,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Jun 30, 2026

WEALTH ENHANCEMENT ADVISORY SERVICES, LLC holds $284,979,146 across 56 Medical Devices names. PACB ranks #43 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PACB

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $92,368 54,981
2026-03-31 $57,632 43,661
2025-12-31 $36,160 19,337
2025-09-30 $22,677 17,717
2025-06-30 $37,340 30,113
2025-03-31 $24,041 20,374
2024-12-31 $42,040 22,973
2024-09-30 $103,346 60,792
2024-06-30 $62,024 45,273
2024-06-30 $68,500 50,000
2024-03-31 $58,413 15,577
2023-12-31 $161,609 16,474
2023-09-30 $117,217 14,038